- Home
- BBIO vs TYL Comparison
BBIO vs TYL Comparison
Compare BBIO & TYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | TYL |
|---|---|---|
| Founded | 2015 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 15.5B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BBIO | TYL |
|---|---|---|
| Price | $77.89 | $423.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 23 |
| Target Price | $106.85 | ★ $446.14 |
| AVG Volume (30 Days) | ★ 2.7M | 770.9K |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.01 |
| EPS | N/A | ★ 6.51 |
| Revenue | ★ $502,076,000.00 | $493,101,000.00 |
| Revenue This Year | $118.43 | $9.37 |
| Revenue Next Year | $51.86 | $9.92 |
| P/E Ratio | ★ N/A | $62.29 |
| Revenue Growth | ★ 126.26 | 18.35 |
| 52 Week Low | $60.55 | $270.71 |
| 52 Week High | $93.42 | $481.57 |
Technical Indicators
Market Signals| Indicator | BBIO | TYL |
|---|---|---|
| Relative Strength Index (RSI) | 65.69 | 68.36 |
| Support Level | $63.16 | $317.01 |
| Resistance Level | $75.91 | N/A |
| Average True Range (ATR) | 2.16 | 14.58 |
| MACD | 1.10 | 3.15 |
| Stochastic Oscillator | 76.06 | 90.78 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.